| 000 | 01766 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517173058.0 | ||
| 264 | 0 | _c20180507 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a0219-6352 | ||
| 024 | 7 |
_a10.3233/JIN-170032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTian, Ji-Sha | |
| 245 | 0 | 0 |
_a2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis. _h[electronic resource] |
| 260 |
_bJournal of integrative neuroscience _c2017 |
||
| 300 |
_a385-400 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAmyloid beta-Peptides |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBenzofurans _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNootropic Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aPeptide Fragments |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSpatial Memory _xdrug effects |
| 650 | 0 | 4 |
_aSpatial Navigation _xdrug effects |
| 700 | 1 | _aZhai, Qi-Jin | |
| 700 | 1 | _aZhao, Ying | |
| 700 | 1 | _aChen, Rui | |
| 700 | 1 | _aZhao, Lian-Dong | |
| 773 | 0 |
_tJournal of integrative neuroscience _gvol. 16 _gno. 4 _gp. 385-400 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/JIN-170032 _zAvailable from publisher's website |
| 999 |
_c27546640 _d27546640 |
||